ArticleCureus2025
Frontal Lobe Cysticercosis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Drug-resistant frontal lobe epilepsy: A review.SAGE open medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cysticercosis, a brain infection caused by the parasite Taenia solium, presents considerable health challenges, especially in tropical and developing areas, where it contributes significantly to the incidence of epilepsy. The lifecycle of this parasite involves humans as the primary hosts and pigs as the intermediate hosts. In this case study, a 12-year-old girl exhibited unusual symptoms, such as fainting episodes and a decline in academic performance. Although she adhered to a vegetarian diet, her contact with pigs resulted in an infection, confirmed by a CT scan that revealed a cyst in the right frontal lobe containing a hyperdense scolex. The treatment regimen included valproic acid, prednisolone, and albendazole, which successfully resolved her seizures over a follow-up period of 24 months. This case underscores the diagnostic challenges associated with cysticercosis and highlights the necessity of identifying atypical cognitive symptoms related to this infection, particularly in populations at risk of exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.